Northern Trust Corp Lineage Cell Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,274,573 shares of LCTX stock, worth $739,252. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,274,573
Previous 1,191,318 6.99%
Holding current value
$739,252
Previous $1.19 Million 2.69%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$0.8 - $1.12 $66,604 - $93,245
83,255 Added 6.99%
1,274,573 $1.16 Million
Q2 2024

Aug 14, 2024
SELL
$0.89 - $1.47 $36,692 - $60,605
-41,228 Reduced 3.34%
1,191,318 $1.19 Million
Q1 2024

May 14, 2024
BUY
$0.86 - $1.48 $32,131 - $55,295
37,362 Added 3.13%
1,232,546 $1.82 Million
Q4 2023

Feb 13, 2024
SELL
$0.91 - $1.35 $7,983 - $11,843
-8,773 Reduced 0.73%
1,195,184 $1.3 Million
Q3 2023

Nov 13, 2023
BUY
$1.16 - $1.53 $116,956 - $154,262
100,825 Added 9.14%
1,203,957 $1.42 Million
Q2 2023

Aug 11, 2023
BUY
$1.26 - $1.53 $1.09 Million - $1.33 Million
866,049 Added 365.29%
1,103,132 $1.56 Million
Q1 2023

May 15, 2023
BUY
$1.2 - $1.53 $16,359 - $20,858
13,633 Added 6.1%
237,083 $355,000
Q3 2022

Nov 14, 2022
BUY
$1.13 - $1.77 $24,492 - $38,364
21,675 Added 10.74%
223,450 $252,000
Q2 2022

Aug 12, 2022
SELL
$1.12 - $1.61 $928,518 - $1.33 Million
-829,034 Reduced 80.43%
201,775 $319,000
Q1 2022

May 13, 2022
SELL
$1.21 - $2.48 $60,639 - $124,285
-50,115 Reduced 4.64%
1,030,809 $1.59 Million
Q4 2021

Feb 08, 2022
SELL
$1.84 - $2.68 $766,733 - $1.12 Million
-416,703 Reduced 27.82%
1,080,924 $2.65 Million
Q3 2021

Nov 15, 2021
SELL
$2.26 - $2.86 $296,335 - $375,008
-131,122 Reduced 8.05%
1,497,627 $3.77 Million
Q2 2021

Aug 13, 2021
BUY
$2.17 - $3.0 $2.89 Million - $4 Million
1,332,456 Added 449.71%
1,628,749 $4.64 Million
Q1 2021

May 12, 2021
BUY
$1.77 - $3.1 $60,647 - $106,218
34,264 Added 13.08%
296,293 $696,000
Q4 2020

Feb 11, 2021
SELL
$0.95 - $1.83 $6,675 - $12,859
-7,027 Reduced 2.61%
262,029 $461,000
Q3 2020

Nov 16, 2020
BUY
$0.75 - $1.09 $19,440 - $28,253
25,921 Added 10.66%
269,056 $252,000
Q2 2020

Aug 14, 2020
SELL
$0.71 - $1.18 $737,988 - $1.23 Million
-1,039,421 Reduced 81.04%
243,135 $211,000
Q1 2020

May 14, 2020
BUY
$0.6 - $1.58 $74,913 - $197,270
124,855 Added 10.78%
1,282,556 $1.06 Million
Q4 2019

Feb 14, 2020
SELL
$0.54 - $1.01 $23,575 - $44,094
-43,658 Reduced 3.63%
1,157,701 $1.03 Million
Q3 2019

Nov 13, 2019
BUY
$0.85 - $1.24 $1.02 Million - $1.49 Million
1,201,359 New
1,201,359 $1.18 Million

Others Institutions Holding LCTX

# of Institutions
121
Shares Held
94.2M
Call Options Held
63.8K
Put Options Held
1K
View Full List

About Lineage Cell Therapeutics, Inc.

LCTX Quotes by TradingView
  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $98.5M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email